Intravenous Paracetamol Vs. Intravenous Tramadol for Labor Analgesia

Published On: 09 Oct, 2023 12:41 PM | Updated On: 09 Oct, 2023 12:47 PM

Intravenous Paracetamol Vs. Intravenous Tramadol for Labor Analgesia

Labor pain ranks among the most agonizing experiences for women. The use of pain relief measures during labor is crucial not only to alleviate maternal distress but also to enhance both maternal and perinatal outcomes. Due to their availability, affordability, and ease of administration, paracetamol and tramadol present practical options for pain management during childbirth.

A recent study compared the efficacy of intravenous paracetamol and intravenous tramadol for labor analgesia. It included 130 patients divided into two groups, where Group A received 1000 mg of intravenous paracetamol and Group B received 100 mg of intravenous tramadol hydrochloride for labor analgesia in the active phase of labor (>/= 4 cm cervical dilatation).

 The study assessed Pain intensity by Visual Analogue scale (VAS) before, after 1 and 3 hours of drug administration. It also evaluated the duration of labor, mode of delivery, drug-delivery interval, maternal side effects, and neonatal outcomes.

The study observed-

  • Inclusion of 130 patients, with 65 in each group. 
  • Significantly lower mean VAS score after 1 and 3 hours of drug administration in Group A than in Group B. 
  • The significantly lower mean duration of 1 stage of labor (210.79±70.49 minutes) and mean drug delivery interval (4.34 hours) in Group A than in Group B (246.95+/-76.09 minutes; 5.17 hours). 
  • More maternal side effects with tramadol than with paracetamol.

This study proves intravenous paracetamol is effective labor analgesia with a lesser VAS score, shorter duration of labor, drug delivery interval, and few maternal side effects.

Marwah M, Mandrelle K, Liddle D, A randomized controlled trial of intravenous paracetamol and intravenous tramadol for labor analgesia. Indian J ObstetGynecol Res. 2023;10(3):259-265

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks